Bortezomib
Who holds supplier records for Bortezomib? 22 organisations hold a current record for Bortezomib: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (12), China (4), Australia (1), Taiwan (1) and 1 other country (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Bortezomib: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/bortezomib
Reading the evidence
- 22 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
12 of the 19 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 11 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (22)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Bortezomib. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 27569, 35755 · latest filing Mar 2021
- SHILPA PHARMA LIFESCIENCES LTDIndiaActive DMF 36821, 24944 · latest filing Mar 2022
- APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC)Active DMF 22922 · latest filing Jun 2009
- ARTHUR GROUP LLCAustraliaActive DMF 38777 · latest filing Aug 2023
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 29506 · latest filing Aug 2015
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 23996 · latest filing Jul 2010
- Gland Chemicals Private LimitedIndiaActive DMF 26440 · latest filing Oct 2012
- Granules India LimitedIndia Company GMP cert on recordActive DMF 34445 · latest filing Jan 2020
- HAINAN SHUANGCHENG PHARMACEUTICALS CO LTDChinaActive DMF 36559 · latest filing Jan 2022
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 25482, 30576 · latest filing Jun 2016
- HUBEI HONCH PHARMACEUTICAL CO LTDCompany GMP cert on recordActive DMF 39499 · latest filing Jun 2024
- Jiangsu Hansoh Pharmaceutical Group Company LimitedChina Company GMP cert on recordActive DMF 32275 · latest filing Jan 2018
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 26774 · latest filing Dec 2012
- Natco PharmaIndia Company GMP cert on recordActive DMF 26547 · latest filing Dec 2012
- Qilu Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 29308 · latest filing May 2015
- Reliance Life Sciences Pvt. Ltd.India Company GMP cert on recordActive DMF 26282 · latest filing Aug 2012
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 25665 · latest filing Dec 2011
- SEACROSS PHARMA USA INCChinaActive DMF 39374 · latest filing Jan 2024
- SHIVALIK RASAYAN LTDIndiaActive DMF 36171 · latest filing Aug 2021
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 28957 · latest filing Jan 2015
- TAPI NL BVNetherlandsActive DMF 22160 · latest filing Oct 2008
- ZYPHAR'S BIOPHARMACEUTICALS PRIVATE LTDActive DMF 44715 · latest filing Aug 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (4)
Organisations whose Type II DMFs for Bortezomib are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- India · Inactive DMF 30264 · filed Mar 2016
- China · Inactive DMF 27432 · filed Sept 2013
- POLYMED THERAPEUTICS INCInactive DMF 25740 · filed Jan 2012
- Viwit Pharmaceutical Co., Ltd.China · Inactive DMF 22884 · filed Jun 2009
Overview
Bortezomib is a proteasome inhibitor used as an anticancer drug for the treatment of multiple myeloma and certain types of lymphoma. It works by interrupting the proteasome pathway, leading to cellular apoptosis in cancer cells.
Chemical identity
- IUPAC name
- [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
- Canonical SMILES
- B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
- InChIKey
- GXJABQQUPOEUTA-RDJZCZTQSA-N
- Synonyms
- Velcade API, bortezomib accord, bortezomib hydrate, ldp-341, nsc-681239, ps-341, velcade
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Proteasome Inhibitor
- Mechanism of action
- Proteasome Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Bortezomib?
22 organisations hold an active US FDA Type II Drug Master File or a CEP for Bortezomib: MSN Laboratories Private Limited (India), SHILPA PHARMA LIFESCIENCES LTD (India), APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC), ARTHUR GROUP LLC (Australia), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Dr. Reddy's Laboratories Ltd. (India), Gland Chemicals Private Limited (India) and Granules India Limited (India), and 14 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Bortezomib Drug Master Files are active?
MSN Laboratories Private Limited (DMF 27569, 35755), SHILPA PHARMA LIFESCIENCES LTD (DMF 36821, 24944), APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC) (DMF 22922), ARTHUR GROUP LLC (DMF 38777), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 29506), Dr. Reddy's Laboratories Ltd. (DMF 23996), Gland Chemicals Private Limited (DMF 26440) and Granules India Limited (DMF 34445) and 14 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Bortezomib records mean?
4 organisations have only inactive Type II DMFs for Bortezomib. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Bortezomib supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Bortezomib?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.